Ruchira Das Gupta at Adnexux / BMS to Speak at 5th Assay Conference September 20-21 in San Diego

NewswireToday - /newswire/ -
Monrovia, CA, United States, 2010/06/21 - This conference will also provide a venue for professionals in the drug discovery industry and academics to get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery.

Ruchira Das Gupta will give a presentation on “Tools and Techniques for Discovery of Adnectins, A Novel Class of Targeted Biologics” at 5th Assay and Drug Discovery Technologies Conference to be held this year in San Diego, CA Sept. 20-21, 2010 by GTCbio. Adnectins™ offer numerous potential advantages compared to traditional targeted biologics, including speed of discovery, ease of manufacturing, and the ability to create multi-functional targeted products. Adnectins are generated using Adnexus’ proprietary protein engineering system, PROfusion™. The presentation outlines Adnexus’ approach in applying PROfusion, as well as automation and screening techniques, to the Adnectin discovery process.

Ruchira Das Gupta received her PhD in human genetics at the Albert Einstein College of Medicine, New York. She developed positional cloning technologies and identified genes associated with a haploinsufficiency syndrome on chromosome 22q. She went on to do postdoctoral research on cancer predisposition at Dana Farber Cancer Institute and Ludwig Institute for Cancer Research. Mutations in mismatch repair genes lead to genetic instability and cancer predisposition—Ruchira used S. cerevisiae as a model system to understand the genetic interactions and biochemistry of some of these proteins. Ruchira joined Compound Therapeutics, (renamed as Adnexus Therapeutics) in 2002 to work on the next generation of protein therapeutics. At Adnexus, Ruchira’s group provides biochemical assay support for targets entering the selection pipeline as well as screening and characterization of the hits from selections.

5th Assay and Drug Discovery Technologies Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, the exchanges of ideas and networking. Professionals in the drug discovery industry and academics to can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output.

Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.